학술논문
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
Document Type
Article
Author
Source
In: JTO Clinical and Research Reports . (JTO Clinical and Research Reports, June 2022, 3(6))
Subject
Language
English
ISSN
26663643